SUBSCRIBE
SUBSCRIBE

BioNTech

NEWS
Drug Development
Clinical Catch-Up: August 17-21
It was a relatively quiet week for clinical trial news. Here’s a look.
August 21, 2020
 · 
5 min read
 · 
Mark Terry
Drug Development
Pfizer and BioNTech Release Additional Early-Stage Data on COVID-19 Vaccine
Today’s data describes key safety and immunogenicity data from the U.S. Phase I study for BNT162b.
August 21, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 21
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.
August 20, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
August 11, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
BioCapital
Clinical Catch-Up: August 3-7
It was a moderately busy week for clinical trial news, with some particularly interesting announcements related COVID-19 vaccine trials. Here’s a look.
August 6, 2020
 · 
8 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
August 4, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Business
Regeneron and BioNTech Partner on Immunotherapy Combo for Melanoma
Regeneron Pharmaceuticals and BioNTech have inked a strategic collaboration to combine BioNTech’s BNT111 FixVac product candidate and Regeneron and Sanofi’s checkpoint inhibitor Libtayo (cemiplimab) for the treatment of melanoma.
August 3, 2020
 · 
2 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.
July 30, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
BioSpace Global Roundup, July 30
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
July 29, 2020
 · 
5 min read
 · 
Alex Keown
Load More
JOBS
IN THE PRESS
Press Releases
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
November 4, 2025
 · 
29 min read
Press Releases
BioNTech to Host Innovation Series R&D Day on November 11, 2025
October 29, 2025
 · 
1 min read
Press Releases
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
October 28, 2025
 · 
2 min read
Press Releases
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
October 22, 2025
 · 
18 min read
Press Releases
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
September 23, 2025
 · 
1 min read
Press Releases
OncoC4 to Present Global Pivotal Phase 3 Trial Design for Next-Generation CTLA-4 Antibody Gotistobart Monotherapy Being Co-Developed with BioNTech in NSCLC at the IASLC 2025 World Conference on Lung Cancer
September 9, 2025
 · 
4 min read
Press Releases
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
September 9, 2025
 · 
19 min read
Press Releases
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
September 9, 2025
 · 
15 min read
Press Releases
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 28, 2025
 · 
19 min read
Press Releases
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
August 18, 2025
 · 
3 min read
Load More